Emergency belzutifan [welireg] for the M'boro VA pharm
Ended Awarded Last action
- Contract number
- 36C24922N0319
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $19,761
Award facts
- Contract value 100% obligated
- $19,761.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the procurement of the emergency oncology medication Belzutifan (WELIREG) by the U.S. Department of Veterans Affairs (VA) for the M'boro VA Pharmacy. The $19,761.11 firm fixed price contract was awarded to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., on May 26, 2022 under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a $3.1 billion ceiling value and runs through August 2024. This delivery order was placed without a set-aside designation, as Janssen Biotech is a large, for-profit pharmaceutical manufacturer. The contract supports the VA's Veterans Health Administration (VHA) in providing critical cancer treatment medications to veterans across the country through the agency's regional Veterans Integrated Service Networks (VISNs).
Quick answers
Who was awarded contract 36C24922N0319?
36C24922N0319 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on May 26, 2022.
How much is contract 36C24922N0319 worth?
The government has obligated $19,761 on 36C24922N0319.
Is contract 36C24922N0319 an order under another contract?
Yes. 36C24922N0319 is a BPA call under 36F79719D0217-36E79720A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24922N0319 competed?
The extent of competition for 36C24922N0319 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award